Other
Prolonged Disorders of Consciousness
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Prolonged Disorders of Consciousness is an early-stage landscape with 0 programs across 1 company. The most active players are Hongying Jiang, MD.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
5
clinical trials
Recruiting1 · 20%
Completed1 · 20%
Unknown status1 · 20%
Not yet recruiting1 · 20%
Enrolling by invitation1 · 20%
Clinical Trials
Trial Activity
Effects of Esketamine on Consciousness-related Brain Network Characteristics in Patients With Prolonged Disorders of Consciousness
Recruiting·—·N/A·NCT06473285·80 enrolled
Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness
Not yet recruiting·—·N/A·NCT07274683·25 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)